Page last updated: 2024-08-22

platinum and cabozantinib

platinum has been researched along with cabozantinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Hayakawa, N; Kikuchi, E	1
Alessi, A; Briganti, A; Calareso, G; Colecchia, M; Madison, R; Marandino, L; Martini, A; Montorsi, F; Necchi, A; Raggi, D; Ross, JS	1

Trials

1 trial(s) available for platinum and cabozantinib

Article	Year
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial. Clinical genitourinary cancer, 2021, Volume: 19, Issue:5 Topics: Anilides; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Platinum; Pyridines; Urinary Bladder Neoplasms	2021

Article

Year

Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial.

Clinical genitourinary cancer, 2021, Volume: 19, Issue:5

Topics: Anilides; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Platinum; Pyridines; Urinary Bladder Neoplasms

2021

Other Studies

1 other study(ies) available for platinum and cabozantinib

Article	Year
Cabozantinib as a choice for platinum-refractory metastatic urothelial cancer. The Lancet. Oncology, 2020, Volume: 21, Issue:8 Topics: Anilides; Carcinoma, Transitional Cell; Humans; Platinum; Pyridines; Urologic Neoplasms	2020